Jan L. Hillson's most recent trade in Eledon Pharmaceuticals Inc was a trade of 30,870 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eledon Pharmaceuticals Inc | Jan L. Hillson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 30,870 | 30,870 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Jan L. Hillson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 3,430 | 3,430 | - | - | Restricted Stock Units | |
| Eledon Pharmaceuticals Inc | Jan L. Hillson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 150,437 | 150,437 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Jan L. Hillson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Eledon Pharmaceuticals Inc | Jan L. Hillson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |